NL
DE
Our purpose
We aim to develop and evaluate novel approaches to prevent the development of neurological movement disorders, and to improve the quality of life of persons affected by these disorders.
Goals
We focus on a well-defined, limited set of conditions: Parkinson’s disease; atypical parkinsonism; rare hereditary movement disorders, in particular cerebellar ataxia and hereditary spastic paraplegia; tremors; and gait and balance disorders. Our goals are:
- Identify pathways for primary, secondary and tertiary prevention.
- Based on these insights: develop and evaluate disease-modifying interventions.
- Study novel symptomatic therapies (both pharmacological as and non-pharmacological).
- Develop novel diagnostic and progression biomarkers, including digital, neurochemical and neuroimaging techniques.
